Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

capstone > Major Depressive Disorder > Flashcards

Major Depressive Disorder Flashcards

Shahid

1
Q

Who is most commonly affected by MDD?

A

Ages 18-29
Women (2:1 ratio compared to males)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Epidemiology of MDD

A

high prevalent (one of the most common psychiatric disorders)
~7% of Americans affected annually (20+ million)
remission rate diminish w each trial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the pathophysiology of MDD?

A

Not clearly defined
Previous trials suggest a disturbance in CNS serotonin (5HT) activity as an important factor
Multifactorial w both genetic and environmental factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the DSM5 criteria of a depressive episode ?

A

5+ of sx (listed below) during same 2 week period
Causes significant distress of functional impairment
Not attributable to physiological effects of substance or other medical conditions

Sx examples: insomnia/hypersomnia, diminished interest/pleasure, guilt/worthlessness, fatigue/loss of energy, low concentration, loss of appetite/weight loss/weight gain, psychomotor, suicidal, depressed mood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What mono-therapeutic tx options are considered first line pharmacotherapy for MDD?

A

SSRI, SNRI, bupropion, mirtazapine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the MOA of SSRIs?

A

Inhibits presynaptic reuptake of 5HT at the 5HT transporter, thus increasing 5HT at the postsynaptic membrane in the serotonergic synapse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the MOA of SNRIs?

A

Inhibits reuptake of 5HT and NE into neurons preventing chemical messengers from being taken back into brain cells that released them thus increasing levels in the brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are some common ADR of SSRI/SNRIs

A

Agitation, increased anxiety, nausea, diarrhea, sexual dysfunction, drowsiness, insomnia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are some SNRI specific ADRs?

A

Increased ocular pressure, elevated BP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are some SSRI agent specific ADRs?

A

Citalopram: risk of prolonged QTc interval (at normal doses)
Escitalopram: risk of prolonged QTc interval (at high supratherapeutic doses)
(citalopram has a higher incidence of QTc interval prolongation)
Fluoxetine: 24-72 hr t1/2, most activating
Paroxetine: greater risk of anticholinergic effects, most sedating
Sertraline: most benign SE profile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are some DDI with SSRI/SNRI?

A

CYP2D6/2C19 inhibition
Tamoxifen (big CYP2D6 inducer)
MAOIs (washout required)
Linezolid
NSAIDs
Triptans
Sympathomimetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the washout period required when switching to or from MAOIs from SSRI/SNRIs?
and what is the important note w this?

A

14 days

Note: not very commonly that you see this, can greatly increase risk of toxicity or hypertensive emergency

Nonselective MAOIs and linezolid do not need washout period

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What should be monitored with SSRI/SNRI?

A

Mood
Adherence
Suicidal Ideation
BP w SNRIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are some warnings with SSRI/SNRI?

A

BBW: increased risk of suicidal thoughts or behaviors in peds and young adults
Serotonin syndrome
Increased bleeding risk
Can precipitate mania

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are some clinical pearls w SSRI/SNRI?

A

Tapering required upon dc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the MOA of bupropion?

A

Not fully understood, weak inhibitor of neuronal uptake of NE and DA, does not inhibit MAO or reuptake of NE and DA, does not inhibit MAO or reuptake of 5HT, metabolite inhibits reuptake of NE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what is the dose of bupropion?

A

150-450 mg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the ADR of bupropion?

A

Dry mouth
Insomnia
Nausea
Decreased appetite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are some DDI w bupropion?

A

CYP2B6 inhibition
CBZ
Ritonavir
Linezolid – hypertensive reactions
MAOIs – hypertensive reactions
TCAs – increases seizure activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What to monitor w bupropion?

A

Seizures
BP
Mood
Suicidal Ideation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are some warnings w bupropion?

A

BBW: increased risk of suicidal thoughts or behavior in peds and young adults
Increases risk of seizures
Can precipitate mania

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are some clinical pearls w bupropion?

A

Tapering is not required but preferred if possible
Avoid alcohol

Myth buster: people assume because bupropion can affect seizure threshold that this must be tapered however in theory this could actually be increasing threshold upon discontinuation, try not to d/c suddenly as it may lead to untreated depression which can be detrimental in and of itself

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the MOA of mirtazapine?

A

Central presynaptic alpha2-adrenergic antagonist effects resulting in increased release in NE and5HT, potent antagonist of 5HT2, 5HT3, H1 receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the dosing for mirtazapine?

A

15-45 mg/day

higher doses for mood
The higher into the dose, you target more mood than sleep

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What are the ADR of mirtazapine?

A

Dry Mouth
Drowsiness
Constipation
Increased appetite

(anticholinergic effects)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What are some DDI w mirtazapine?

A

CYP1A2/2D6/3A4 inhibition
MAOIs
Linezolid
Clonidine
Triptans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What should be monitored w mirtazapine?

A

mood
suicidal ideation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What are some warnings w mirtazapine?

A

BBW: increased risk of suicidal thoughts or behavior in peds and young adults
May overly sedate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are some clinical pearls w mirtazapine?

A

tapering required

30
Q

What is Treatment Resistant Depression (TRD)?

A

Two adequate trials of 4-12 weeks of different antidepressants and lack of full response to each

31
Q

What are some tx strategies for TRD?

A

Switch= if all first line agents have not been trialed still considered first line, if they have consider TCAs or MAOIs

Augmentation= w lithium, thyroid hormone, or an SGA

If patient has shown partial response, “keeping initial med and augmentation is best to ensure clinical effect already gained is not lost”

32
Q

What agents/drugs/classes can be used for switch strategy in TRD?

A

SSRIs
SNRIs
Bupropion
Mirtazapine
TCAs
MAOis

33
Q

What are some ADR of TCAs?

A

Sedating
Anticholinergic
Cardiac conduction abnormalities: cardiotoxicity/prolong qrs/qt intervals
Weight Gain

34
Q

What are some DDI w TCAs?

A

Hepatic metabolism: 2D6, 2C19 inhibitor
CBZ, rifampin
Cimetidine, fluoxetine, paroxetine
FQ, ziprasidone, quinidine, procainamide, sympathomimetics

35
Q

What should be monitored w TCAs?

A

EKG
HR
BP
Electrolytes
Mood
Suicidal ideation

36
Q

What are some warnings w TCAs?

A

BBW: increased risk of suicidal thoughts or behavior in peds and young adults
May precipitate mania

37
Q

What are some clinical pearls of TCAs?

Include theraupeutic ranges of specific TCAs mentioned

A

Tapering required

Therapeutic ranges:
Amitriptyline: 80-200 ng/ml
Doxepin: 50-150 ng/ml
Nortriptyline: 50-100 ng/ml

38
Q

What are some ADR of MAOIs?

A

Orthostatic HoTN
Dry Mouth
Constipation
Dizziness, HA
Sexual dysfunction
Weight gain
Insomnia
Patch = diarrhea

39
Q

What are some DDI w MAOi?

A

Atomoxetine, bupropion, CBZ, insulins, linezolid, SSRIs, SNRIs, tramadol, triptans, TCAs, tyramine foods, levodopa, dextromethorphan, sympathomimetics, etc

40
Q

What should be monitored w MAOIs?

A

Renal Function
BP/HR
Mood
Suicidal ideation

41
Q

What are some warnings w MAOIs?

A

BBW: increased risk of suicidal thoughts or behavior in peds and young adults
Can cause HTN crises and/or orthostatic HoTN
May precipitate mania

42
Q

What are some clinical pearls w MAOIs?

A

Requires low tyramine diet
- Tyramine: aged cheeses, alcohol (wine and beer), chocolate, coffee, soy sauce, etc.

Requires 14 day washout period from other serotonergic agents*

*5 weeks washout for fluoxetine bc of long t1/2

43
Q

What are some agents/drugs/classes that may be used in augmentation strategy in TRD?

A

Lithium
Thyroid Hormone (T3)
SGAs

44
Q

What are some ADR of Lithium?

A

Arrhythmias, Drowsiness, Acne, GI effects, Sexual dysfunction, Tremor
Polyuria, Weight gain
Thirst, diarrhea

45
Q

What are some DDI w Lithium?

A

ACEi, caffeine, NSAIDs, thiazides, diuretics, theophylline

46
Q

What are some warnings w Lithium?

A

BBW: lithium toxicity
Levels of > 1.5 typically is toxic level
– sx of toxicity include nausea, tremors, confusion, arrhythmias, overly sedated, slurred speech

47
Q

What should be monitored w Lithium?

A

Renal function
Lithium levels
Thyroid
Mood

48
Q

What are some clinical pearls w Lithium?

A

Consistent fluid intake
Target level: 0.4-0.6

49
Q

What are some ADR of SGAs?

A

Constipation, endocrine abnormalities, EPS, drowsiness, QTc prolongation

50
Q

What are some DDI w SGAs?

A

DA agonists (ropinirole, pramiprexole, bromocriptine)
QTc prolonging agents

51
Q

What should be monitored w SGAs?

A

BMI/weight gain
A1c/glucose
EPS
Lipids
EKG
Mood

52
Q

What are some warnings w SGAs?

A

Caution in patients w Parkinson’s Disease

53
Q

What are some clinical pearls w SGAs?

A

Dosing is lower for MDD dosing compared to dosing for other indications

54
Q

What are some ADR of Thyroid Hormone?

A

Diarrhea, HA, nervousness, irritability tachycardia, sweating

55
Q

What are some DDI of T3?

A

Separate out from other meds by ~ 4 hours

56
Q

What should be monitored w T3?

A

Thyroid function tests,
Mood
HP/BP
Cardiac abnormalities

57
Q

What are some warnings w T3?

A

May result in decreased bone mineral density
Caution in patients w adrenal insufficiency and/or cardiac issues

58
Q

What are some clinical pearls of T3?

A

Administered same time each day

59
Q

What is the most compelling choice of TRD treatment for younger patients or those who are not great w adherence ?

A

Fluoxetine (t1/2 24-72 hours)

60
Q

What is the most compelling choice of TRD treatment for those w concomitant pain conditions?

A

SNRIs, TCAs

61
Q

What is the most compelling choice of TRD treatment for those seeking weight loss and/or tobacco use?

A

Bupropion

62
Q

What is the most compelling choice of TRD treatment for those who need appetite stimulation and/or need for sleep

A

Mirtazapine

63
Q

What is the most compelling choice of TRD treatment for those w concurrent psychiatric disorders?

A

Lithium, SGAs

64
Q

What is the most compelling choice of TRD treatment for those w concurrent hypothyroidism?

A

Liothyronine

65
Q

What are some general monitoring parameters for MDD?

A

mood, adherence, suicidal ideation, BMI/weight gain, EPS, A1c/glucose, lipids, EKG, BP, renal function

(some of these may be patient-case specific)

66
Q

What is the criteria for maintenance treatment of MDD?

A

Those who experience 2+ MDD episodes
Family hx of bipolar disorder or MDD
Co-occurring SUD or psych disorder

67
Q

What is the minimum duration of continuation treatment for MDD?

A

6-9 months after sx remission

Same dose as sx remission
duration varies between 1 year and lifetime dependent on recurrence and pt preference

68
Q

What is the adequate length of trials for antidepressant treatment of MDD?

A

6-12 weeks

69
Q

When does a patient qualify for TRD?

A

When they had an adequate trial of two or more antidepressants w no sx remission

70
Q

What are the different strategies of TRD?

A

Switch and augmentation

capstone (14 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions